Mylan pays $750mm, plus earn-outs, for women's health firm Famy Care
Mylan Inc., through its Mylan Laboratories Ltd. division, will pay $750mm in cash to acquire privately held women’s health company Famy Care Ltd. The deal also includes up to $50mm in earn-outs.
- In Vitro Diagnostics
- Generic Drugs
- Implantable Devices
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.